Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Lowered to $2.25 at Canaccord Genuity Group

Bioceres Crop Solutions (NASDAQ:BIOXFree Report) had its price target trimmed by Canaccord Genuity Group from $2.50 to $2.25 in a report issued on Friday,Benzinga reports. The brokerage currently has a hold rating on the stock.

BIOX has been the topic of a number of other research reports. Lake Street Capital lowered their price objective on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Oppenheimer cut Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a report on Wednesday, October 22nd. Wall Street Zen lowered Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, September 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Bioceres Crop Solutions in a research report on Wednesday, October 8th. Finally, Brookline Capital Management cut Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 21st. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Bioceres Crop Solutions has a consensus rating of “Hold” and a consensus price target of $4.08.

Read Our Latest Stock Analysis on Bioceres Crop Solutions

Bioceres Crop Solutions Stock Down 1.8%

NASDAQ:BIOX traded down $0.03 during mid-day trading on Friday, hitting $1.68. 499,556 shares of the company’s stock were exchanged, compared to its average volume of 989,396. The company has a market cap of $106.22 million, a PE ratio of -2.00 and a beta of 0.42. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. Bioceres Crop Solutions has a one year low of $1.20 and a one year high of $7.44. The business has a fifty day moving average price of $1.74 and a 200 day moving average price of $3.24.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in BIOX. Jones Financial Companies Lllp boosted its stake in Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after buying an additional 5,339 shares during the period. Bank of America Corp DE raised its position in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after purchasing an additional 3,735 shares during the period. Virtu Financial LLC bought a new stake in Bioceres Crop Solutions in the third quarter worth about $40,000. PDT Partners LLC purchased a new position in shares of Bioceres Crop Solutions during the first quarter valued at approximately $81,000. Finally, Avanza Fonder AB raised its holdings in shares of Bioceres Crop Solutions by 62.9% in the second quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock worth $117,000 after buying an additional 10,099 shares during the period. Institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Further Reading

Analyst Recommendations for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.